Innovation Offsets Hero Image

Technological changes can balance or recoup the investments made to create them. Amid pricing and market pressures, these opportunities and increases in resource efficiency can help enhance the patient experience and improve R&D potential and returns.


LATEST ARTICLES


RELATED ARTICLES

Moving Toward a Value-Driven Health Care System image

Moving Toward a Value-Driven Health Care System

To advance a value-driven care system, we need better information, a focus on outcomes that matter to patients and flexible new approaches to paying for medicines.

Improving Health Care Quality While Reducing Costs thumbnail

Improving Health Care Quality While Reducing Costs

The latest immunosuppressant therapies are transforming the lives of patients in ways beyond physical success. Innovations in treatment not only help extend life, they can also reduce health care costs to give back confidence and hope to patients for the future.

A New Era for Vaccines thumbnail

A New Era for Vaccines

National Immunization Awareness Month, sponsored every August by the National Public Health Informat…

Innovative Medicines Deserve an Innovative Payment System image

Innovative Medicines Deserve an Innovative Payment System

Over the past several years, we've witnessed an unprecedented pace of innovation which has ushered in a new era of medicine.

Technology and Health Care Working Together to Improve Patient Care image

Technology and Health Care Working Together to Improve Patient Care

Pairing technology and medicine together has the potential to create revolutions in health care that were once considered unimaginable. But finding the right combination is tricky.

We Cannot Take Progress for Granted

Policy Solutions to Push Progress Forward

We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.

Our Commitment Image

Our Commitment

We are America's Biopharmaceutical Companies, driven to discover the next lifesaving breakthrough and dedicated to ending the burdens of disease. And with new, innovative medicines on the horizon, we're closer than ever to reaching our goal.

A Critical Quest: Working Toward Better Treatments for Brain Cancer

A Critical Quest: Working Toward Better Treatments for Brain Cancer

Glioblastoma is the most aggressive form of brain cancer, and one that impacts more than 12,000 Americans each year.

Researcher Profile: Dan Skovronsky image

Researcher Profile: Dan Skovronsky

A neuroscientist and neuropathologist by training, Dan is responsible for development across all of Lilly's products - from clinical trials through approvals - specifically working within the areas of oncology, diabetes, Alzheimer's disease, immunology and pain management.

The New Era of Medicine with Stephen Ubl image

The New Era of Medicine with Stephen Ubl

We are in a new era of medicine where innovations are transforming our ability to attack the cause o…

Lifecycle from Brand to Generic image

Lifecycle from Brand to Generic

Where do generic drugs come from? Medicines have a long lifecycle from research to brand name drug to generic form. Over time, innovation leads to increased competition on price and clinical effects.

Research Doesn’t End on A Medicine’s Approval image

Research Doesn’t End On A Medicine’s Approval

Research on a medicine doesn't end on the initial approval by the FDA. Eli Lilly and Company's chief medical officer shares why ongoing research helps us better understand a medicine's full value.

Can We Afford the New Era of Medicine

Can We Afford the New Era of Medicine?

Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.

The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors image

The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors

Investment is a key driver of innovation across all industries. However, investment is especially important to the research-intensive biopharmaceutical industry.

A New Age of Viral Disease Treatment: The Cure Developed by Biopharmaceutical Companies that Saved a Mother of Six image

A New Age of Viral Disease Treatment: The Cure Developed by Biopharmaceutical Companies that Saved a Mother of Six

Hepatitis C kills more Americans than any other infectious disease. Carleen was one of those affected. She had five children and was pregnant with her sixth when she was diagnosed with the disease.